which permits unrestricted noncommercial use, provided the original work is properly cited. Clinical Pharmacology: Advances and Applications 2013:5 143–148 Clinical Pharmacology: Advances and Applications

Results of prophylaxis of venous thromboembolism after orthopedic operations

B. S. Sukovatykh
M. B. Sukovatykh
S. O. Per’Kov

October 2017

OBJECTIVE. The research compared efficacy and safety of application of dabigatran and rivaroxaban in...

Use of rivaroxaban in Germany: A database drug utilization study of a drug started in hospital.

Jobski, K.
Amann, U.
Suzart, K.
Wallander, M.A.
Schink, T.
Garbe, E.

January 2014

Purpose The purpose of this drug utilization study was to describe the use of rivaroxaban in Germany...

Management consensus guidance for the use of rivaroxaban - an oral, direct factor Xa inhibitor

Turpie, Alexander G. G.
Kreutz, Reinhold
Llau, Juan
Norrving, Bo
Haas, Sylvia

January 2012

A number of novel oral anticoagulants that directly target factor Xa or thrombin have been developed...

Rivaroxaban for venous thromboembolism prevention after total knee arthroplasty

Ageno W.

January 2009

Patients undergoing major orthopaedic surgery are at considerable risk for venous thromboembolism in...

which permits unrestricted noncommercial use, provided the original work is properly cited. Vascular Health and Risk Management 2012:8 363–370 Vascular Health and Risk Management

André C Schmidt
Reinhold Kreutz
Michael R Lassen
Waheed Jamal
Lorenzo Mantovani
Sylvia Haas
Pharmakologie Und Toxikologie
Correspondence Alex
Er Gg Turpie

October 2016

Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thro...

Therapeutic potential of rivaroxaban in the prevention of venous thromboembolism following hip and knee replacement surgery: a review of clinical trial data

Kwong LM

July 2011

Louis M KwongDepartment of Orthopaedic Surgery, Harbor-UCLA Medical Center, Torrance, CA, USAAbstrac...

New compounds in the management of venous thromboembolism after orthopedic surgery: focus on rivaroxaban

Lars Carl Borris

August 2008

Lars Carl BorrisDepartment of Orthopaedic Surgery, Åarhus University Hospital, Åarhus, D...

which permits unrestricted noncommercial use, provided the original work is properly cited. Journal of Multidisciplinary Healthcare 2013:6 215–228 Journal of Multidisciplinary Healthcare Transitions of care in anticoagulated patients

Franklin Michota

August 2016

Abstract: Anticoagulation is an effective therapeutic means of reducing thrombotic risk in patients ...

Rivaroxaban Versus Enoxaparin for Venous Thromboembolism Prophylaxis after Hip and Knee Arthroplasty.

Charters, Michael A
Frisch, Nicholas
Wessell, Nolan M
Dobson, Christopher
Les, Clifford M
Silverton, Craig D

July 2015

The oral Factor Xa inhibitor rivaroxaban (Xarelto) has been the pharmacologic agent used for venous ...

Rivaroxaban for Thromboprophylaxis After Nonelective Orthopedic Trauma Surgery in Switzerland

Hoffmeyer, Pierre
Simmen, Hanspeter
Jakob, Marcel
Sommer, Christoph
Platz, Andreas
Ilchmann, Thomas
Grossen, Erik
Ryf, Christian
Christofilopoulos, Panayiotis
Schueler, Michael
Lassen, Michael Rud
Rimle, Markus
Gasser, Urs E

January 2017

This study investigated the effectiveness and the outcomes of rivaroxaban vs the standard of care fo...

in Patients Undergoing Hip or Knee Replacement

Pulmonary Embolism
David Van Thiel
Rakesh Wahi Md Evan Litinas
Wasimul Haque
Gundu Rao

September 2016

surgery reducing the Risk of DVT and PE (RECORD) clinical program of rivaroxaban consists of 4 phase...

Rivaroxaban for thromboprophylaxis after nonelective orthopedic trauma surgery in Switzerland

Hoffmeyer, Pierre
Simmen, Hanspeter
Jakob, Marcel
Sommer, Christoph
Platz, Andreas
Ilchmann, Thomas
Grossen, Erik
Ryf, Christian
Christofilopoulos, Panayiotis
Schueler, Michael
Lassen, Michael Rud
Rimle, Markus
Gasser, Urs E

January 2017

This study investigated the effectiveness and the outcomes of rivaroxaban vs the standard of care fo...

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty

Lassen, Michael R.
Ageno, Walter
Borris, Lars C.
Lieberman, Jay R.
Rosencher, Nadia
Bandel, Tiemo J.
Misselwitz, Frank
Turpie, Alexander G. G.
RECORD3 Investigators, The

January 2008

We investigated the efficacy of rivaroxaban, an orally active direct factor Xa inhibitor, in prevent...

Systematic review of prophylaxis for venous thromboembolism after knee arthroplasty: enoxaparin versus rivaroxaban.

Rodrigo Ribeiro Pinho Rodarte (6698996)
João Antônio Matheus Guimarães (6698999)
José Sérgio Franco (6699002)
Lorran Fonseca (6699005)
Vilker Nascimento (6699008)
José Paulo Gabbi Aramburu (6699011)
João Mauricio Barretto (6699014)

May 2019

ABSTRACT Total knee arthroplasty is an elective procedure performed on relatively healthy individual...

Rivaroxaban in preventing venous thromboembolism after arthroplastic surgery in Taiwan

Mao, Yun-Chuan
Chen, Shih-Tse
Chen, Chung-Hwan
Hsieh, Kun-Pin
Gan, Kim-Hong

October 2015

AbstractVenous thromboembolism (VTE) is one of the severe complications of total hip arthroplasty (T...

Results of prophylaxis of venous thromboembolism after orthopedic operations

B. S. Sukovatykh
M. B. Sukovatykh
S. O. Per’Kov

October 2017

OBJECTIVE. The research compared efficacy and safety of application of dabigatran and rivaroxaban in...

Use of rivaroxaban in Germany: A database drug utilization study of a drug started in hospital.

Jobski, K.
Amann, U.
Suzart, K.
Wallander, M.A.
Schink, T.
Garbe, E.

January 2014

Purpose The purpose of this drug utilization study was to describe the use of rivaroxaban in Germany...

Management consensus guidance for the use of rivaroxaban - an oral, direct factor Xa inhibitor

Turpie, Alexander G. G.
Kreutz, Reinhold
Llau, Juan
Norrving, Bo
Haas, Sylvia

January 2012

A number of novel oral anticoagulants that directly target factor Xa or thrombin have been developed...

Rivaroxaban for venous thromboembolism prevention after total knee arthroplasty

Ageno W.

January 2009

Patients undergoing major orthopaedic surgery are at considerable risk for venous thromboembolism in...

which permits unrestricted noncommercial use, provided the original work is properly cited. Vascular Health and Risk Management 2012:8 363–370 Vascular Health and Risk Management

André C Schmidt
Reinhold Kreutz
Michael R Lassen
Waheed Jamal
Lorenzo Mantovani
Sylvia Haas
Pharmakologie Und Toxikologie
Correspondence Alex
Er Gg Turpie

October 2016

Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thro...

Therapeutic potential of rivaroxaban in the prevention of venous thromboembolism following hip and knee replacement surgery: a review of clinical trial data

Kwong LM

July 2011

Louis M KwongDepartment of Orthopaedic Surgery, Harbor-UCLA Medical Center, Torrance, CA, USAAbstrac...

New compounds in the management of venous thromboembolism after orthopedic surgery: focus on rivaroxaban

Lars Carl Borris

August 2008

Lars Carl BorrisDepartment of Orthopaedic Surgery, Åarhus University Hospital, Åarhus, D...

which permits unrestricted noncommercial use, provided the original work is properly cited. Journal of Multidisciplinary Healthcare 2013:6 215–228 Journal of Multidisciplinary Healthcare Transitions of care in anticoagulated patients

Franklin Michota

August 2016

Abstract: Anticoagulation is an effective therapeutic means of reducing thrombotic risk in patients ...

Rivaroxaban Versus Enoxaparin for Venous Thromboembolism Prophylaxis after Hip and Knee Arthroplasty.

Charters, Michael A
Frisch, Nicholas
Wessell, Nolan M
Dobson, Christopher
Les, Clifford M
Silverton, Craig D

July 2015

The oral Factor Xa inhibitor rivaroxaban (Xarelto) has been the pharmacologic agent used for venous ...

Rivaroxaban for Thromboprophylaxis After Nonelective Orthopedic Trauma Surgery in Switzerland

Hoffmeyer, Pierre
Simmen, Hanspeter
Jakob, Marcel
Sommer, Christoph
Platz, Andreas
Ilchmann, Thomas
Grossen, Erik
Ryf, Christian
Christofilopoulos, Panayiotis
Schueler, Michael
Lassen, Michael Rud
Rimle, Markus
Gasser, Urs E

January 2017

This study investigated the effectiveness and the outcomes of rivaroxaban vs the standard of care fo...

in Patients Undergoing Hip or Knee Replacement

Pulmonary Embolism
David Van Thiel
Rakesh Wahi Md Evan Litinas
Wasimul Haque
Gundu Rao

September 2016

surgery reducing the Risk of DVT and PE (RECORD) clinical program of rivaroxaban consists of 4 phase...

Rivaroxaban for thromboprophylaxis after nonelective orthopedic trauma surgery in Switzerland

Hoffmeyer, Pierre
Simmen, Hanspeter
Jakob, Marcel
Sommer, Christoph
Platz, Andreas
Ilchmann, Thomas
Grossen, Erik
Ryf, Christian
Christofilopoulos, Panayiotis
Schueler, Michael
Lassen, Michael Rud
Rimle, Markus
Gasser, Urs E

January 2017

This study investigated the effectiveness and the outcomes of rivaroxaban vs the standard of care fo...

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty

Lassen, Michael R.
Ageno, Walter
Borris, Lars C.
Lieberman, Jay R.
Rosencher, Nadia
Bandel, Tiemo J.
Misselwitz, Frank
Turpie, Alexander G. G.
RECORD3 Investigators, The

January 2008

We investigated the efficacy of rivaroxaban, an orally active direct factor Xa inhibitor, in prevent...

Systematic review of prophylaxis for venous thromboembolism after knee arthroplasty: enoxaparin versus rivaroxaban.

Rodrigo Ribeiro Pinho Rodarte (6698996)
João Antônio Matheus Guimarães (6698999)
José Sérgio Franco (6699002)
Lorran Fonseca (6699005)
Vilker Nascimento (6699008)
José Paulo Gabbi Aramburu (6699011)
João Mauricio Barretto (6699014)

May 2019

ABSTRACT Total knee arthroplasty is an elective procedure performed on relatively healthy individual...

Rivaroxaban in preventing venous thromboembolism after arthroplastic surgery in Taiwan

Mao, Yun-Chuan
Chen, Shih-Tse
Chen, Chung-Hwan
Hsieh, Kun-Pin
Gan, Kim-Hong

October 2015

AbstractVenous thromboembolism (VTE) is one of the severe complications of total hip arthroplasty (T...

Results of prophylaxis of venous thromboembolism after orthopedic operations

B. S. Sukovatykh
M. B. Sukovatykh
S. O. Per’Kov

October 2017

OBJECTIVE. The research compared efficacy and safety of application of dabigatran and rivaroxaban in...

Use of rivaroxaban in Germany: A database drug utilization study of a drug started in hospital.

Jobski, K.
Amann, U.
Suzart, K.
Wallander, M.A.
Schink, T.
Garbe, E.

January 2014

Purpose The purpose of this drug utilization study was to describe the use of rivaroxaban in Germany...

Management consensus guidance for the use of rivaroxaban - an oral, direct factor Xa inhibitor

Turpie, Alexander G. G.
Kreutz, Reinhold
Llau, Juan
Norrving, Bo
Haas, Sylvia

January 2012

A number of novel oral anticoagulants that directly target factor Xa or thrombin have been developed...

which permits unrestricted noncommercial use, provided the original work is properly cited. Clinical Pharmacology: Advances and Applications 2013:5 143–148 Clinical Pharmacology: Advances and Applications

Abstract

Extracted data

which permits unrestricted noncommercial use, provided the original work is properly cited. Clinical Pharmacology: Advances and Applications 2013:5 143–148 Clinical Pharmacology: Advances and Applications

Abstract

Extracted data

Related items

Related items